Bavarian Nordic — Maj 2023
-
- chikungunya - han forventer denne vaccine kan være en driver af omsætning og cash-flow indenfor en kortere tidsperiode. Markedsstørrelse 500 mio. usd./år.
-
09:58 var ikke mindet på Covid, men mere et
supplement til pkt. 3) -
-
@WhiteWiseWolf: tusind tak for din udlæg og videregivelse af DB konference!
-
“SSI: Tegn på stigning i tilfælde af skildkopper” https://ekstrabladet.dk/nyheder/samfund/ssi-tegn-paa-stigning-i-tilfaelde-af-skoldkopper/9771126
-
skoldkopper
-
-
Måske er denne allerede bragt her i Forum, men synes ikke jeg fandt den 5 sider bagud. https://emergency.cdc.gov/han/2023/han00490.asp
-
Although vaccine-induced immunity is not complete, vaccination continues to be one of the most important prevention measures. CDC expects new cases among previously vaccinated people to occur, but people who have completed their two-dose JYNNEOS vaccine series may experience less severe symptoms than those who have not.
Spring and summer season in 2023 could lead to a resurgence of mpox as people gather for festivals and other events. The purpose of this Health Alert Network (HAN) Health Update
-
Og denne er ikke så gammel med henviser til samme https://eu.usatoday.com/story/news/health/2023/05/16/what-is-mpox-symptoms-vaccines-cases/70222162007/
-
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States https://www.nejm.org/doi/full/10.1056/NEJMoa2215201
-
2 doses of mpox vaccine were 86% effective against infection: CDC https://abcnews.go.com/amp/Health/2-doses-mpox-vaccine-86-effective-infection-cdc/story?id=99422859
-
..stærke tal fra CDC der…det er dette studie der underbygger den nye kampagne vil jeg tro…
-
Bava er ikke selv klar over, hvor travlt de får
-
Her fyldestgørende beskrivelse af de 3 studier der underbygger tallene fra CNN https://amp.cnn.com/cnn/2023/05/18/health/mpox-vaccine-jynneos-results/index.html
-
..og som klart understreger at det ikke kun var adfærdsændringer der stoppede udbruddet sidste år.
-
Fantastiske nyheder ja..og Bavarian nordics navn igen all over the medias
-
Kort video: Opdatering: Zealand Pharma' Bavarian' Hansa Biopharma - Fantastisk udvikling i aktiekursen for Zealand Pharma. Det går hedt for sig i Bavarian Nordic-chatten - men hvad er selskabets business case? Hansa Biopharma afventer grønt lys til at køre videre i accelereret proces med stof inden for genterapi - og hvis det lykkes med en eventuel endelig fremtidig godkendelse, ser det for alvor godt ud for selskabet. https://www.proinvestor.com/boards/112684/
-
…får mig til at tro, at vi ser en større ordre fra US på den nuværende liquid frozen inden længe, at de altså ikke venter på den frysetørrede..kun 25% af højrisiko gruppen er vaccineret pt., ca 1,2 mio doser anvendt.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind